Giaginis C - Search Results

1

Clinical utility of microRNAs in renal cell carcinoma: current evidence and future perspectives.

Tsiakanikas P, Giaginis C, Kontos CK, Scorilas A. Tsiakanikas P, et al. Among authors: giaginis c. Expert Rev Mol Diagn. 2018 Nov;18(11):981-991. doi: 10.1080/14737159.2018.1539668. Epub 2018 Oct 26. Expert Rev Mol Diagn. 2018. PMID: 30345829 Review.

2

Angiogenesis in salivary gland tumors: from clinical significance to treatment.

Theocharis S, Gribilas G, Giaginis C, Patsouris E, Klijanienko J. Theocharis S, et al. Among authors: giaginis c. Expert Opin Ther Targets. 2015 Jun;19(6):807-19. doi: 10.1517/14728222.2015.1016424. Epub 2015 May 8. Expert Opin Ther Targets. 2015. PMID: 25956454 Review.

3

Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival.

Theocharis S, Giaginis C, Alexandrou P, Rodriguez J, Tasoulas J, Danas E, Patsouris E, Klijanienko J. Theocharis S, et al. Among authors: giaginis c. Tumour Biol. 2016 Mar;37(3):3647-56. doi: 10.1007/s13277-015-4182-8. Epub 2015 Oct 12. Tumour Biol. 2016. PMID: 26459312

4

Salivaomics for oral diseases biomarkers detection.

Tasoulas J, Patsouris E, Giaginis C, Theocharis S. Tasoulas J, et al. Among authors: giaginis c. Expert Rev Mol Diagn. 2016;16(3):285-95. doi: 10.1586/14737159.2016.1133296. Epub 2016 Jan 11. Expert Rev Mol Diagn. 2016. PMID: 26680995 Review.

5

Phosphorylated Epidermal Growth Factor Receptor Expression Is Associated With Clinicopathologic Parameters and Patient Survival in Mobile Tongue Squamous Cell Carcinoma.

Theocharis S, Giaginis C, Dana E, Thymara I, Rodriguez J, Patsouris E, Klijanienko J. Theocharis S, et al. Among authors: giaginis c. J Oral Maxillofac Surg. 2017 Mar;75(3):632-640. doi: 10.1016/j.joms.2016.08.022. Epub 2016 Aug 27. J Oral Maxillofac Surg. 2017. PMID: 27657462

6

HuR as Therapeutic Target in Cancer: What the Future Holds.

Goutas D, Pergaris A, Giaginis C, Theocharis S. Goutas D, et al. Among authors: giaginis c. Curr Med Chem. 2022;29(1):56-65. doi: 10.2174/0929867328666210628143430. Curr Med Chem. 2022. PMID: 34182901 Review.

7

Clinical significance of MCM-2 and MCM-5 expression in colon cancer: association with clinicopathological parameters and tumor proliferative capacity.

Giaginis C, Georgiadou M, Dimakopoulou K, Tsourouflis G, Gatzidou E, Kouraklis G, Theocharis S. Giaginis C, et al. Dig Dis Sci. 2009 Feb;54(2):282-91. doi: 10.1007/s10620-008-0305-z. Epub 2008 May 9. Dig Dis Sci. 2009. PMID: 18465232

8

MCM proteins as diagnostic and prognostic tumor markers in the clinical setting.

Giaginis C, Vgenopoulou S, Vielh P, Theocharis S. Giaginis C, et al. Histol Histopathol. 2010 Mar;25(3):351-70. doi: 10.14670/HH-25.351. Histol Histopathol. 2010. PMID: 20054807 Review.

9

Cranberry as promising natural source of potential anticancer agents: current evidence and future perspectives.

Katsargyris A, Tampaki EC, Giaginis C, Theocharis S. Katsargyris A, et al. Among authors: giaginis c. Anticancer Agents Med Chem. 2012 Jul;12(6):619-30. doi: 10.2174/187152012800617669. Anticancer Agents Med Chem. 2012. PMID: 22043998 Review.

10

Current evidence for histone deacetylase inhibitors in pancreatic cancer.

Koutsounas I, Giaginis C, Patsouris E, Theocharis S. Koutsounas I, et al. Among authors: giaginis c. World J Gastroenterol. 2013 Feb 14;19(6):813-28. doi: 10.3748/wjg.v19.i6.813. World J Gastroenterol. 2013. PMID: 23430136 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

201 results

Search Page